Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

GNI Group Ltd

3G6
Current price
17.9 EUR 0 EUR (0.00%)
Last closed 3 090 JPY
ISIN JP3386370005
Sector Healthcare
Industry Biotechnology
Exchange Frankfurt Exchange
Capitalization 145 104 736 356 JPY
Yield for 12 month +47.06 %
1Y
3Y
5Y
10Y
15Y
3G6
21.11.2021 - 28.11.2021

GNI Group Ltd. engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally. It provides Etuary for the treatment of idiopathic pulmonary fibrosis. The company is also developing Etuary, which is in Phase III clinical trial for the treatment of connective tissue associated interstitial lung disease; and in clinical trial pre-phase III clinical trial pilot study for the treatment of radiation pneumonitis, as well as for the treatment of diabetic nephropathy. In addition, it is involved in developing F351, which is in Phase III clinical trial for the treatment of liver fibrosis; and F573 that is in phase II for the treatment of acute on chronic liver failure, as well as Tamibarotene for the treatment of acute promyelocytic leukemia. GNI Group Ltd. was incorporated in 2001 and is headquartered in Tokyo, Japan. Address: Nihonbashi-Honcho YS Building, Tokyo, Japan, 103-0023

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

627 115.5 JPY

P/E ratio

20.4083

Dividend Yield

Current Year

+25 999 856 528 JPY

Last Year

+17 411 790 580 JPY

Current Quarter

+5 782 868 953 JPY

Last Quarter

+5 946 118 589 JPY

Current Year

+22 421 935 003 JPY

Last Year

+14 738 483 318 JPY

Current Quarter

+4 834 562 636 JPY

Last Quarter

+4 729 542 969 JPY

Key Figures 3G6

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 1 543 363 978 JPY
Operating Margin TTM -9.02 %
PE Ratio 20.4083
Return On Assets TTM 0.87 %
PEG Ratio
Return On Equity TTM 16.83 %
Wall Street Target Price 627 115.5 JPY
Revenue TTM 23 637 259 707 JPY
Book Value 735.54 JPY
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -41.5 %
Dividend Yield
Gross Profit TTM 14 737 926 529 JPY
Earnings per share 137.09 JPY
Diluted Eps TTM 137.09 JPY
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 36.8 %
Profit Margin 28.61 %

Dividend Analytics 3G6

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 3G6

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 3:1
Payout Ratio
Last Split Date 02.09.2019
Dividend Date

Stock Valuation 3G6

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 20.4083
Forward PE
Enterprise Value Revenue 5.2809
Price Sales TTM 6.3406
Enterprise Value EBITDA 11.2152
Price Book MRQ 3.8037

Financials 3G6

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 3G6

For 52 weeks

1 536.37 JPY 3 863.41 JPY
50 Day MA 2 508.59 JPY
Shares Short Prior Month
200 Day MA 2 578.96 JPY
Short Ratio
Shares Short
Short Percent